2010
DOI: 10.1113/jphysiol.2009.184754
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity

Abstract: Adipose tissue exerts important endocrine and metabolic functions in health and disease. Yet the bioenergetics of this tissue is not characterized in humans and possible regional differences are not elucidated. Using high resolution respirometry, mitochondrial respiration was quantified in human abdominal subcutaneous and intra-abdominal visceral (omentum majus) adipose tissue from biopsies obtained in 20 obese patients undergoing bariatric surgery. Mitochondrial DNA (mtDNA) and genomic DNA (gDNA) were determi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
104
0
5

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(121 citation statements)
references
References 37 publications
11
104
0
5
Order By: Relevance
“…Interestingly, whereas multilocular, UCP1-expressing brown adipocyte-like cells (i.e., beige/ BRITE adipocytes) are readily induced in vivo upon ATRA by guest, on www.jlr.org treatment in the subcutaneous (inguinal) WAT of mice, in the visceral depots ATRA treatment increases OXPHOS capacity without inducing the appearance of such cells [this work and ( 11 )]. Subcutaneous WAT is more prone to browning than visceral WAT ( 43 ), whereas rodent and human visceral adipocytes contain more mitochondria and have higher oxidative capacity as compared with subcutaneous adipocytes ( 44,45 ). It would appear, therefore, that ATRA treatment is able to potentiate differential intrinsic capacities of each type of fat depot, thus enhancing energy expenditure by an UCP1-dependent mechanism in subcutaneous WAT and by an UCP1-independent mechanism in the visceral WAT depots.…”
Section: Discussionmentioning
confidence: 98%
“…Interestingly, whereas multilocular, UCP1-expressing brown adipocyte-like cells (i.e., beige/ BRITE adipocytes) are readily induced in vivo upon ATRA by guest, on www.jlr.org treatment in the subcutaneous (inguinal) WAT of mice, in the visceral depots ATRA treatment increases OXPHOS capacity without inducing the appearance of such cells [this work and ( 11 )]. Subcutaneous WAT is more prone to browning than visceral WAT ( 43 ), whereas rodent and human visceral adipocytes contain more mitochondria and have higher oxidative capacity as compared with subcutaneous adipocytes ( 44,45 ). It would appear, therefore, that ATRA treatment is able to potentiate differential intrinsic capacities of each type of fat depot, thus enhancing energy expenditure by an UCP1-dependent mechanism in subcutaneous WAT and by an UCP1-independent mechanism in the visceral WAT depots.…”
Section: Discussionmentioning
confidence: 98%
“…Quantification of genomic and mitochondrial DNA (mtDNA) was measured as described by Kraunsoe et al [19] Blood samples were collected in chilled tubes and immediately centrifuged for 10 min (2,500g; 4°C). The plasma fraction was collected and stored at −20°C or −80°C prior to analysis.…”
Section: Methodsmentioning
confidence: 99%
“…Research in humans on hepatic energy metabolism under conditions of type 2 diabetes mellitus, insulin resistance and non-alcoholic fatty liver disease revealed reduced HEPs content, decreased ATP recovery and altered flux through ATP synthase (for review see Koliaki and Roden (2013)). Mitochondrial transmembrane potential, inorganic phosphate utilization (indicative of ATP synthase capacity), and the activities of respiratory chain complexes I-IV in subcutaneous white adipose tissue were all reduced in obese and type 2 diabetes mellitus patients compared to those in control subjects (Kraunsøe et al 2010;Chattopadhyay et al 2011). Obesity and insulin resistance were also associated with impaired bioenergetics following exercise in overweight-to-obese children (Slattery et al 2014;Wells et al 2017) and adults (Valkovič et al 2013), as evaluated via slower mitochondrial oxidative capacity recovery in the skeletal muscle.…”
Section: Cardiometabolic Diseases and Impaired Bioenergeticsmentioning
confidence: 87%